Evidera @evideraglobal Twitter profile

Last Seen Profiles

@Haj_Amireshoon

@seoojoon

@_m1d8

@MiNimmm2006

@Sitifatmah42

@StephenMarth

@soka99nrious

@BinorRaja

@stw_pdg

@Abo707odE

@9e9y1hizoxv

@bokeplokalmalam

@Njuniosilva

@aaayakkaa_002

@AsbeMaxi

@26MoreLives

@_20rm

@p0werrtv

@nekobola

@4s2Nx7sw7dHcFpJ

@kimkimdaya

@Jacksontsanchez

@ibalpinar

@26MoreLives

@JLEdwardsIII

@kanan_ria333

@adal_koji

@bokeplokalmalam

@aileen1218maimi

@amornextdoor

@drMuhammdkashif

@_Gb1n

@GeromanAT

@gruzabik01

@xusix

@nydelbutera

Evidera

@evideraglobal

7 years

Webinar: Social Media: A Rich Data Source or a Can of Worms? A Guide to Using Health-Related Social Media in Pharma

1

3

116

Evidera

@evideraglobal

7 years

Don't miss our #REMS webinar Oct 4: Hot Topics for Risk Evaluation & Mitigation Strategy (REMS) Programs. Register:

0

3

37

Evidera

@evideraglobal

7 years

Register for Kevin's webinar on May 3 at 10am: Quantitative Benefit-Risk Assessment in Drug Development

0

4

25

Evidera

@evideraglobal

9 years

Report 1 of ISPOR MCDA Emerging Good Practices Task Force viewed 2,500+ times, and now Report 2 is out! Read it now:

0

7

27

Evidera

@evideraglobal

7 years

Upcoming webinar Jul 26 @ 10amET: Value Frameworks: Impact to Date, Future Prospects & Advice for Drug Manufacturers

0

6

26

Evidera

@evideraglobal

6 years

Webinar on July 11! Register to learn: the current methodological trends on the role of RWE in NMAs; when RWE should be considered in NMAs alongside RCTs; and the challenges in the interpretation of NMA results when RWE is synthesized with RCT data.

1

6

24

Evidera

@evideraglobal

6 years

Webinar May 30 10amET! We will share insights on: the background of the directive and EU HTA collaborations; the EU HTA components included; the proposed structure for EU HTA activities; and implications for industry and stakeholders. Register now:

0

7

19

Evidera

@evideraglobal

8 years

Upcoming webinar on Jan 31 at 10amET: Implementing a Common Data Model in a Real-World Informatics & Analytics Env

0

1

18

Evidera

@evideraglobal

7 years

The first collection on the methods & applications of MCDA in healthcare: #MCDA to Support Healthcare Decisions

0

6

17

Evidera

@evideraglobal

6 years

Upcoming webinar Oct 18: Evidera has developed an oncology value frameworks tool that allows the user to compare their product's value across various frameworks (NCCN, ASCO, ESMO, MSKCC, ICER). Register today:

0

1

15

Evidera

@evideraglobal

8 years

1st of our 3-part webinar series: Incorporating Patient Preferences into Product Development & Value Communication

0

5

12

Evidera

@evideraglobal

5 years

Agencies are more interested than ever in incorporating patient preference information into HTA. Register for our October 15th webinar to understand when and how patient preference information can support HTA submissions:

0

7

13

Evidera

@evideraglobal

7 years

Evalytica: Cloud-based software for collaborative real-world data analytics. Now with new analysis apps!

1

9

Evidera

@evideraglobal

6 years

Learn how CTS can support early #marketaccess planning by predicting a range of feasible trial results while making it possible to anticipate challenges to the #economicvalue story of new treatments that may result:

1

4

9

Evidera

@evideraglobal

8 years

Upcoming webinar on Wed Apr 20 at 10amET: Real-World Data Strategy & Efficiencies in Late Phase Study Designs

1

2

9

Evidera

@evideraglobal

6 years

Upcoming webinar on Oct 25: Gather insight into data collection considerations within EAPs and gain a better understanding of best practices and key considerations for implementing data collection & disseminating real-world evidence within EAPs:

0

8

Evidera

@evideraglobal

4 years

Our thought leaders are excited to share their #HEOR insights at #ISPOREurope 2020. Visit our website to see a full list of presentations, including workshops, issue panels, podium presentations, and posters, and to set up a virtual meeting with our staff:

0

1

8

Evidera

@evideraglobal

5 years

Evidera to acquire Medimix, expanding solutions for real-world research. Read the press release:

Evidera to Acquire Medimix, Expanding Solutions for Real-World Research - Evidera

Evidera, a business of Pharmaceutical Product Development, LLC (PPD) and a leading provider of evidence-based solutions demonstrating the real-world effectiveness, safety and value of health care...

www.evidera.com

0

4

8

Evidera

@evideraglobal

5 years

We are proud to be part of an organization that is recognized for supporting #biopharma clients in developing new #anticancer therapies

PPD

@PPDCRO

5 years

PPD has been named Best CRO Provider for the second time in the last three years at the World ADC Awards. Read more: .

1

5

12

0

2

8

Evidera

@evideraglobal

5 years

Evidera and CSS collaborate to develop joint real-world and patient-centered research capabilities in Japan

0

3

7

Evidera

@evideraglobal

8 years

Meet us at ISPOR DC, booth 87/88, to learn more about Discretely Integrated Condition Event (DICE) simulation

0

3

6

Evidera

@evideraglobal

7 years

Evalytica: Cloud-based software for collaborative real-world data analytics. Now with new analysis apps!

0

2

6

Evidera

@evideraglobal

8 years

Upcoming webinar March 7: #Pregnancy Registries and #Lactation Studies: Best Practices to Support Product Labeling

0

5

6

Evidera

@evideraglobal

4 years

We want to know your preferences on #vaccines for #COVID19 . Take this short survey on COVID-19 vaccine scenarios to share your opinion. All answers will be recorded anonymously & we will share the results once the survey has concluded #patientpreference

0

4

5

Evidera

@evideraglobal

7 years

EMA-HTA Parallel Scientific Advice: Early Dialogue to Support Marketing Authorization & Market Access. Whitepaper

0

2

5

Evidera

@evideraglobal

7 years

Don't miss David's webinar May 2 at 10am! Understand future cost pressures, how payers will react to them & more

0

2

4

Evidera

@evideraglobal

7 years

New Pub: The #COPD CBQC Database: Baseline Characteristics of the SGRQ Dataset @COPDFoundation

0

3

5

Evidera

@evideraglobal

7 years

New publication in JAMA: Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

0

2

5

Evidera

@evideraglobal

5 years

Learn innovative techniques for capturing patient insights as well as a framework for some best practices for engaging patients in our upcoming webinar - register today:

0

2

4

Evidera

@evideraglobal

5 years

Do you have what it takes to conduct high-quality systematic literature reviews (SLRs)? Our Evidence Synthesis, Modeling & Communication team is seeking a Senior Research Associate in Waltham or London with proven experience in SLR methods - learn more:

0

3

Evidera

@evideraglobal

4 years

Regulators and sponsors are looking towards patient-informed protocol design (PIPD) to incorporate the #patientvoice in product development. Join our #webinar on June 30th to gain insight into identifying the challenges to implementing PIPD:

0

1

4

Evidera

@evideraglobal

5 years

Erem Latif shares her thoughts on how the patient-centricity movement is continuing to take shape, with patient engagement and involvement in protocol design, preference studies, and more in a recent Q&A with – click here:

0

3

4

Evidera

@evideraglobal

8 years

Congrats to the FLU-PRO team on their "Best General Poster Research Presentation" award!

0

3

Evidera

@evideraglobal

5 years

Benefit‐risk assessment is used in various phases along the drug lifecycle. Researchers argue that for better decisions, different healthcare stakeholder preferences in benefit‐risk decisions should more often be quantified and communicated explicitly:

0

3

Evidera

@evideraglobal

6 years

Register for our upcoming webinar on wearables in clinical trials and learn about the potential challenges, current best practices, and ongoing research efforts for data handling and analysis from wearable technology data.

1

3

4

Evidera

@evideraglobal

9 years

Evalytica, a cloud-based, SaaS platform, enables rapid analysis of healthcare data

0

4

Evidera

@evideraglobal

4 years

The @EMA_News recently released “'Regulatory Science to 2025”, which highlights the use of #patientpreferences in regulatory decision making. Tommi Tervonen provides insights on what this means for #pharma . Learn more about our patient pref experience:

0

2

4

Evidera

@evideraglobal

5 years

Evidera thought leaders are participating in an #ISPORAnnual spotlight session TODAY from 2:15-3:15pm

0

1

3

Evidera

@evideraglobal

3 years

In this recent article from @pharmasalmanac , our subject matter experts discuss how decentralized trials address enrollment challenges in oncology research. Read now: #COVID19 #virtualtrials

0

1

4

Evidera

@evideraglobal

7 years

November is #COPDawarenessMonth . 15M in the US have COPD & an addtl 15M dont know they do #GoOrange

0

1

4

Evidera

@evideraglobal

9 years

Pub: Systematic Review of Model-Based Economic Eval of Treatments for #Alzheimers more info:

0

1

4

Evidera

@evideraglobal

5 years

Evidera experts, along with our new partners from CSS, are excited to be at #ICPEPhilly – stop by booth #202 to discuss the latest in #pharmacoepidemiology and therapeutic #riskmanagement

0

2

4

Evidera

@evideraglobal

3 years

Register for our #SMDM21 short course to hear Jaime Caro and Jorgen Moller discuss how to design and implement a DICE model to structure anything from simple survival partition through Markov models, microsimulation and discrete event simulations: @socmdm

0

2

4

Evidera

@evideraglobal

7 years

Using Real-World Evidence ( #RWE ) in Payer Negotiations - What's in Your Playbook? Read our whitepaper

0

2

4

Evidera

@evideraglobal

5 years

Schedule a meeting or stop by booth #22107 to speak with our experts at #ASCO19

PPD

@PPDCRO

5 years

#ASCO19 in Chicago is just one week away. Have you scheduled your meeting yet?

0

1

4

0

1

4

Evidera

@evideraglobal

7 years

Upcoming webinar Dec 19! Understand what payers consider a low-cost comparator, gain insight into the strategies that do and do not work in a low-cost comparator environment, and obtain recommendations for launching in a low-cost comparator environment...

0

3

4

Evidera

@evideraglobal

5 years

NICE recently provided guidance on how #patientpreference data can support reimbursement decisions. Kevin Marsh highlights key takeaways and what the guidance could mean for those considering the role of patient pref data in evidence generation planning:

0

1

3

Evidera

@evideraglobal

8 years

Whitepaper: Data Needs & Challenges in Cancer Epi: A U.S. Real-World Database Perspective

0

3

Evidera

@evideraglobal

5 years

Learn from our experts on how shifts in the biotech industry require a change in how we approach research, diagnostics, & patients in @Mediaplanet ’s Business & Tech Education article, “Current Trends and Advancements in Biotechnology are Changing Lives.”

0

2

3

Evidera

@evideraglobal

6 years

Evidera supports #WorldCancerDay - with over 1600 research projects in 30+ cancer types and approx. 130 #oncology publications, our researchers understand the unique challenges associated with oncology product development and #marketaccess

0

1

3

Evidera

@evideraglobal

4 years

Our experts are here to help you navigate the latest insights during the #COVID19 pandemic, such as the @US_FDA 's special emergency program designed to expedite the availability of COVID-19 treatments as well as changes to advice programs. Learn more:

0

3

Evidera

@evideraglobal

7 years

Today is #RareDiseaseDay ! Find out more about how you can participate on the Rare Disease Day website: . To learn more about how Evidera supports orphan and #rarediseases , click here:

0

3

Evidera

@evideraglobal

1 year

Phil Leventhal will join the speaker panel at #EMWA55 , leading the “Abstracts” core workshop on 11 May and “A Structured Approach to Developing #MedicalWriting Content” workshop on 12 May. Learn more about the work of Phil and our team. »

0

3

Evidera

@evideraglobal

8 years

Whitepaper: #Oncology Treatments, Health-Related Quality of Life, and Value Assessments

0

3

Evidera

@evideraglobal

7 years

Congrats to Eric Faulkner on his recent collaboration with ARM and NAMCP on a study of payer & provider medical director perspectives on value demonstration & reimbursement for regenerative & advanced therapies. Read more: @alliancerm @NAMCP

0

1

3

Evidera

@evideraglobal

4 years

Register for part three of our @GlobalGenes #webinar series to explore some of the common gaps that occur when #raredisease patients enter a reimbursement environment:

0

3

Evidera

@evideraglobal

4 years

Our study on #patientpreferences for attributes of Ph+ ALL treatments, in collaboration with @TakedaOncology and @LLSusa , was selected as a best practice case study on patient engagement in the @PFMDWithPatient Book of Good Practices. Learn more: #leukemia

0

1

3

Evidera

@evideraglobal

3 years

Discover how preference studies in #oncology can support treatments along the development lifecycle in our on-demand #webinar :

0

3

Evidera

@evideraglobal

7 years

New Pub: PRO and ObsRO Assessments in #RareDisease #ClinicalTrials : An ISPOR Task Force Report @ISPORJournals

0

1

3

Evidera

@evideraglobal

6 years

NICE recently announced that their Scientific Advice team has provided its first piece of advice on the design of a patient preference study. Read the full article here:

0

3

Evidera

@evideraglobal

5 years

ONE month until #ISPOREurope - be sure to join us for an ISPOR advanced workshop to identify and discuss the opportunities and challenges when incorporating patient preference data into reimbursement and pricing decisions:

0

1

3

Evidera

@evideraglobal

10 years

Don't miss this #ISPORAmst forum w/ Kevin Marsh: Intro to MCDA in Health Care Decision Making - Emerging Good Practices, Mon, 6pm, Aud

0

3

Evidera

@evideraglobal

8 years

Whitepaper: Projecting Overall Survival with Immuno-Oncology Treatments

0

3

Evidera

@evideraglobal

4 years

Our thought leaders are excited to share their #HEOR insights at Virtual #ISPORAnnual 2020. Visit our website to see a full list of presentations and to set up a virtual meeting with our staff:

0

3

Evidera

@evideraglobal

8 years

New Pub: ISPOR Comments on the American Society of Clinical #Oncology Value Framework

0

2

Evidera

@evideraglobal

7 years

Be sure to read our article on: Real-world data – optimising your strategy for market access success #RWD #RWE

pharmaphorum

@pharmaphorum

7 years

Have you heard? The latest issue of #DeepDive : Market Access II is out now! Get your free copy now:

0

1

3

Evidera

@evideraglobal

4 years

We are excited to announce our @PharmaVOICE award winners! Congratulations to Karen Kaucic, President, and Rhonda Henry, Vice President, Patient-Centered Trials, for being recognized as part of the #PharmaVOICE100 . Read more in today’s release:

PPD

@PPDCRO

4 years

We are honored to announce PPD senior leaders, Karen Kaucic, M.D., chief medical officer of PPD and president of Evidera, and Rhonda Henry, VP of patient-centered trials, have been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences industry.

0

3

11

0

3

Evidera

@evideraglobal

8 years

Evidera has one of the largest, most well-respected teams in the industry - meet our experts!

0

1

2

Evidera

@evideraglobal

5 years

Tomorrow, join our experts at #ISPORAnnual as they provide a basic understanding of the concepts of discretely-integrated condition event (DICE) simulation as it is applied in HTA during their short course

0

1

3

Evidera

@evideraglobal

4 years

We are committed to Alzheimer’s Disease patients and their caregivers. Learn about our experience conducting a wide range of global studies as we honor #WorldAlzheimersDay :

0

3

Evidera

@evideraglobal

7 years

Innovative approaches to randomized trials can bridge the intersection of observational RWE and the conventional RCT. Learn more about our Pragmatic Studies.

0

1

3

Evidera

@evideraglobal

8 years

Whitepaper: #3DPrinting is Revolutionizing the Medical Devices World, but are Payers Ready?

0

2

3

Evidera

@evideraglobal

5 years

Thank you to all who stopped by our booth at #DIA2019 this past week! Did you miss our innovation theater presentation at #DIA2019 ? Access the presentation online:

0

1

3

Evidera

@evideraglobal

5 years

Learn how integrated regulatory and HTA scientific advice and multi-country collaborations in the EU can help #raredisease evidence planning to increase access for patients in our white paper

0

1

3

Evidera

@evideraglobal

7 years

Congratulations to Tommi Tervonen on co-authoring a paper that Omega Journal awarded the 'Best Paper of 2017!' (Heuristics For Prioritizing Pair-Wise Elicitation Questions with Additive Multi-Attribute Value Models)

0

3

Evidera

@evideraglobal

4 years

Register for Jaime Caro and Jörgen Möller's short course at #SMDM20 on Tuesday, October 13th, from 1:00 – 4:00pm EDT to gain insight into designing and implementing DICE simulations of decision-analytic modeling:

0

3

Evidera

@evideraglobal

5 years

#ISPORAnnual is just over two weeks away - have you set up a time to meet with our experts at booth 503? Click here to schedule a meeting: Learn more about our presentations at ISPOR here:

0

2

3

Evidera

@evideraglobal

5 years

Evidera is proud to support the first annual #RareCancerDay . Our researchers have collaborated with experts in the #oncology field to conduct studies on the safety and efficacy of treatments for rare cancers. Click here to learn more:

1

3

Evidera

@evideraglobal

4 years

We are thrilled to announce the launch of our Summer 2021 US #Internship Program! Our advanced degree #interns will experience our commitment to shaping diverse minds while promoting a culture where differences are acknowledged & valued. Apply today:

0

3

Evidera

@evideraglobal

8 years

Visit booth 6 @ #ICPEDublin to discuss your RWE challenges & opportunities w Evidera experts

0

1

3

Evidera

@evideraglobal

7 years

We are honored to be among the winners of NQF's 2017 Innovation Challenge focused on #patient -centered healthcare measurement. @NatQualityForum

0

3

Evidera

@evideraglobal

8 years

Whitepaper: The Importance of RWE Generation in Oncology. Applications of Retrospective Chart Review Methodology

0

1

3

Evidera

@evideraglobal

5 years

Heather Gelhorn, Senior Research Leader, Patient-Centered Research, collaborated w/ others on a phase 3 trial to eval. pexidartinib in patients w/ TGCT to provide them w/ a viable systemic treatment option. Read more in this study published in The Lancet:

0

2

3

Evidera

@evideraglobal

9 years

Evalytica team expands presence with new PA office! Read more here:

0

1

2

Evidera

@evideraglobal

7 years

New pub: Comprehensive Reporting in Cost-Effectiveness Modeling in @ASCO 's Journal of Clinical Oncology

0

2

3

Evidera

@evideraglobal

8 years

Stop by booth 87/88 & drop your business card 4 a chance to win the book: Discrete Event Simulation for HTA #ISPORDC

0

3

Evidera

@evideraglobal

5 years

Evidera recently had the opportunity to speak with members of CADTH about their two new parallel #scientificadvice programs with the National Institute of Health (NICE) and Health Canada. Read the full interview here: @CADTH_ACMTS

0

2

3

Evidera

@evideraglobal

5 years

A fascinating discussion on new real-world data platforms for clinical research at DIA’s Real-World Evidence Conference last week. Thanks to all who joined Debra Schaumberg, and experts from HLT, Medable, and MIT CBI! #RWE19

0

2

3

Evidera

@evideraglobal

8 years

Whitepaper: Oncology Treatments, Health-Related Quality of Life, and Value Assessments

0

3

Evidera

@evideraglobal

3 years

In this #blog , Jennifer Hill, research scientist, discusses the increasing importance of implementation science studies as healthcare systems look to maximize effectiveness of treatments and care approaches amid resource constraints. Read now:

0

3

Evidera

@evideraglobal

6 years

#WorldKidneyDay is next week. Learn more about this important global campaign, how you can help, as well as events you can participate in around the world.

0

3

Evidera

@evideraglobal

8 years

New article: Real-world data in the United Kingdom: opportunities and challenges #RWE #RWD

0

3

Evidera

@evideraglobal

5 years

It's not too late! Register for tomorrow's webinar: Optimizing Clinical Trials for Commercial Success. Learn how market access can be optimized by integrating HTA & payer perspectives in development planning, while preserving trial efficiency.

0

2

Evidera

@evideraglobal

7 years

PRIME Turns One - PRIME and Other Early Access Tools. Read more

0

1

2

Evidera

@evideraglobal

4 years

Be sure to check out the latest issue of The Evidence Forum in between virtual #ISPORAnnual sessions to get the latest insights from our experts on key issues around the scientific, strategic, and operational challenges of today's #healthcare environment

0

2

Evidera

@evideraglobal

7 years

New: CE Analysis of Dabigatran vs Rivaroxaban for Stroke Prevention in NVAF Patients Using Real-World Evidence #AFib

0

1